In 62 patients aged ≥6 years with allergic fungal rhinosinusitis, dupilumab improved Lund-Mackay CT sinus opacification score at 52 weeks versus placebo (LSMD −7.36; P<.001), and cut need for systemic corticosteroids and/or sinonasal surgery by 92%.
RCTn = 62
Luong et al. Dupilumab for patients with allergic fungal rhinosinusitis